RECRUITING

Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Safe and Fast Radial Hemostasis using Synergistic Strategies (SAFE \& FAST) trial is an interventional study aimed at reducing the incidence of radial artery occlusion (RAO) rebound bleeding, and the required compression time after transradial approach (TRA) procedures, which have become the default access for coronary procedures globally. The hypothesis is that combining lower-dose heparin and radial hemostasis with simultaneous ipsilateral ulnar artery compression could achieve these improved outcomes.

Official Title

Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial

Quick Facts

Study Start:2024-08-15
Study Completion:2026-08-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06549842

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patients referred for diagnostic transradial cardiac catheterization
  2. 2. Age ≥ 18 years
  3. 3. Ability to provide written informed consent
  1. 1. Absence of written informed consent
  2. 2. Patients on long-term systemic anticoagulation therapy for a different indication
  3. 3. Patients requiring a heparin dose of greater than 50 units per kilogram before, during, or after the procedure for any reason.
  4. 4. Patients requiring greater than 6 French catheter access

Contacts and Locations

Study Contact

Khyati Khattar, MD
CONTACT
5702092088
khyati.khatter@gmail.com

Principal Investigator

Nishant Sethi, MD
PRINCIPAL_INVESTIGATOR
Regional Hospital of Scranton

Study Locations (Sites)

Regional Hospital of Scranton
Scranton, Pennsylvania, 18510
United States

Collaborators and Investigators

Sponsor: Regional Hospital of Scranton

  • Nishant Sethi, MD, PRINCIPAL_INVESTIGATOR, Regional Hospital of Scranton

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-15
Study Completion Date2026-08-15

Study Record Updates

Study Start Date2024-08-15
Study Completion Date2026-08-15

Terms related to this study

Keywords Provided by Researchers

  • Radial artery occlusion
  • Rebound Bleeding
  • Transradial access
  • Coronary angiography

Additional Relevant MeSH Terms

  • Cardiovascular Diseases
  • Bleeding
  • Arterial Puncture
  • Catheter Complications
  • Occlusion of Artery